{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:46:26Z","timestamp":1794671186206,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The contribution of the gut microbiome to chronic heart failure (HF) remains poorly defined. We performed integrated microbiome and host multi-omic profiling of adults with chronic systolic HF due to nonischemic cardiomyopathy (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200959) and healthy participants (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200950), including longitudinal sampling in some cases. Here we show that patients with HF have depletion of anti-inflammatory\n                    <jats:italic>Bifidobacterium<\/jats:italic>\n                    and reduced short-chain fatty acid biosynthetic potential, alongside altered microbiome\u2013immune system interactions. Longitudinal analysis revealed that higher\n                    <jats:italic>Bifidobacterium<\/jats:italic>\n                    abundance was associated with clinical improvement. Multi-omic integration prioritized indole-3-propionic acid (IPA), a gut metabolite with cardioprotective properties, as a candidate mechanistic link. We confirmed that\n                    <jats:italic>Bifidobacterium<\/jats:italic>\n                    species can produce IPA in vitro and circulating IPA levels were associated with milder HF severity. Together, these findings define gut microbiome alterations in chronic systolic HF, identify candidate microbiome biomarkers of disease severity and trajectory, and suggest microbiome-derived metabolites as potential therapeutic targets.\n                  <\/jats:p>","DOI":"10.1038\/s44161-026-00854-y","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:02:44Z","timestamp":1790240564000},"page":"1055-1070","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gut microbiome shifts in chronic systolic heart failure are associated with disease severity and clinical improvement"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1301-5925","authenticated-orcid":false,"given":"Petra","family":"Mamic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1688-6905","authenticated-orcid":false,"given":"Handuo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6244-8781","authenticated-orcid":false,"given":"Nasim","family":"Bararpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Contrepois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyjun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Avina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6311-6671","authenticated-orcid":false,"given":"Sophia Miryam","family":"Sch\u00fcssler-Fiorenza Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Kotaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran Kaur","family":"Khush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-735X","authenticated-orcid":false,"given":"W. H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin L.","family":"Sonnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8043-8138","authenticated-orcid":false,"given":"Kerwyn Casey","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0784-7987","authenticated-orcid":false,"given":"Michael P.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"854_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.cardfail.2025.07.007","volume":"32","author":"GC Fonarow","year":"2026","unstructured":"Fonarow, G. C. et al. HF STATS 2025: heart failure epidemiology and outcomes statistics an updated 2025 report from the Heart Failure Society of America. J. Card. Fail. 32, 439\u2013498 (2026).","journal-title":"J. Card. Fail."},{"key":"854_CR2","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","volume":"375","author":"SV Lynch","year":"2016","unstructured":"Lynch, S. V. & Pedersen, O. The human intestinal microbiome in health and disease. N. Engl. J. Med. 375, 2369\u20132379 (2016).","journal-title":"N. Engl. J. Med."},{"key":"854_CR3","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/CIRCRESAHA.125.325516","volume":"136","author":"M Snelson","year":"2025","unstructured":"Snelson, M. et al. Gut\u2013heart axis: the role of gut microbiota and metabolites in heart failure. Circ. Res. 136, 1382\u20131406 (2025).","journal-title":"Circ. Res."},{"key":"854_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18756-2","volume":"8","author":"X Cui","year":"2018","unstructured":"Cui, X. et al. Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients. Sci. Rep. 8, 635 (2018).","journal-title":"Sci. Rep."},{"key":"854_CR5","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jacc.2017.12.057","volume":"71","author":"M Kummen","year":"2018","unstructured":"Kummen, M. et al. Gut microbiota signature in heart failure defined from profiling of 2 independent cohorts. J. Am. Coll. Cardiol. 71, 1184\u20131186 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"854_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jchf.2015.10.009","volume":"4","author":"E Pasini","year":"2016","unstructured":"Pasini, E. et al. Pathogenic gut flora in patients with chronic heart failure. JACC Heart Fail. 4, 220\u2013227 (2016).","journal-title":"JACC Heart Fail."},{"key":"854_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41591-022-01688-4","volume":"28","author":"S Fromentin","year":"2022","unstructured":"Fromentin, S. et al. Microbiome and metabolome features of the cardiometabolic disease spectrum. Nat. Med. 28, 303\u2013314 (2022).","journal-title":"Nat. Med."},{"key":"854_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01296-6","volume":"16","author":"SC Raju","year":"2024","unstructured":"Raju, S. C. et al. Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity. Genome Med. 16, 27 (2024).","journal-title":"Genome Med."},{"key":"854_CR9","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.118.036652","volume":"139","author":"H Bartolomaeus","year":"2019","unstructured":"Bartolomaeus, H. et al. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage. Circulation 139, 1407\u20131421 (2019).","journal-title":"Circulation"},{"key":"854_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1161\/CIRCULATIONAHA.118.035235","volume":"139","author":"WH Tang Tony","year":"2019","unstructured":"Tang Tony, W. H. et al. Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair. Circulation 139, 647\u2013659 (2019).","journal-title":"Circulation"},{"key":"854_CR11","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & B\u00e4ckhed, F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332\u20131345 (2016).","journal-title":"Cell"},{"key":"854_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41385-020-0296-4","volume":"14","author":"A Iljazovic","year":"2021","unstructured":"Iljazovic, A. et al. Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation. Mucosal. Immunol. 14, 113\u2013124 (2021).","journal-title":"Mucosal. Immunol."},{"key":"854_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00737-2","author":"F Violi","year":"2022","unstructured":"Violi, F. et al. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat. Rev. Cardiol. https:\/\/doi.org\/10.1038\/s41569-022-00737-2 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"854_CR14","doi-asserted-by":"publisher","first-page":"eabp9960","DOI":"10.1126\/science.abp9960","volume":"377","author":"J-Y Lee","year":"2022","unstructured":"Lee, J.-Y., Tsolis, R. M. & B\u00e4umler, A. J. The microbiome and gut homeostasis. Science 377, eabp9960 (2022).","journal-title":"Science"},{"key":"854_CR15","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.aam9949","volume":"357","author":"MX Byndloss","year":"2017","unstructured":"Byndloss, M. X. et al. Microbiota-activated PPAR-\u03b3-signaling inhibits dysbiotic Enterobacteriaceae expansion. Science 357, 570\u2013575 (2017).","journal-title":"Science"},{"key":"854_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1161\/CIRCRESAHA.123.322381","volume":"134","author":"Y-C Wang","year":"2024","unstructured":"Wang, Y.-C. et al. Indole-3-propionic acid protects against heart failure with preserved ejection fraction. Circ. Res. 134, 371\u2013389 (2024).","journal-title":"Circ. Res."},{"key":"854_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fmed.2021.648259","volume":"8","author":"M Gesper","year":"2021","unstructured":"Gesper, M. et al. Gut-derived metabolite indole-3-propionic acid modulates mitochondrial function in cardiomyocytes and alters cardiac function. Front. Med. 8, 264 (2021).","journal-title":"Front. Med."},{"key":"854_CR18","first-page":"382","volume":"83","author":"C Li","year":"2024","unstructured":"Li, C., Chang, J., Wang, Y. & Pan, G. Indole-3-propionic acid, a product of intestinal flora, inhibits the HDAC6\/NOX2 signalling and relieves doxorubicin-induced cardiomyocyte damage. Folia Morphol. 83, 382\u2013390 (2024).","journal-title":"Folia Morphol."},{"key":"854_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58107-8","volume":"16","author":"R Huang","year":"2025","unstructured":"Huang, R. et al. Microbiota\u2013indole-3-propionic acid\u2013heart axis mediates the protection of leflunomide against \u03b1PD1-induced cardiotoxicity in mice. Nat. Commun. 16, 2651 (2025).","journal-title":"Nat. Commun."},{"key":"854_CR20","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","volume":"75","author":"SP Murphy","year":"2020","unstructured":"Murphy, S. P., Kakkar, R., McCarthy, C. P. & Januzzi, J. L. Inflammation in heart failure. J. Am. Coll. Cardiol. 75, 1324\u20131340 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"854_CR21","doi-asserted-by":"publisher","unstructured":"Lozupone, C. A. Unraveling interactions between the microbiome and the host immune system to decipher mechanisms of disease. mSystems 3, e00183-17 https:\/\/doi.org\/10.1128\/mSystems.00183-17 (2018).","DOI":"10.1128\/mSystems.00183-17"},{"key":"854_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-019-1236-x","volume":"569","author":"W Zhou","year":"2019","unstructured":"Zhou, W. et al. Longitudinal multi-omics of host\u2013microbe dynamics in prediabetes. Nature 569, 663\u2013671 (2019).","journal-title":"Nature"},{"key":"854_CR23","doi-asserted-by":"publisher","first-page":"2222961","DOI":"10.1080\/19490976.2023.2222961","volume":"15","author":"B N\u00fcse","year":"2023","unstructured":"N\u00fcse, B., Holland, T., Rauh, M., Gerlach, R. G. & Mattner, J. l-arginine metabolism as pivotal interface of mutual host\u2013microbe interactions in the gut. Gut Microbes 15, 2222961 (2023).","journal-title":"Gut Microbes"},{"key":"854_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106931","volume":"196","author":"R Mollace","year":"2023","unstructured":"Mollace, R. et al. Modulation of the nitric oxide\/cGMP pathway in cardiac contraction and relaxation: potential role in heart failure treatment. Pharmacol. Res. 196, 106931 (2023).","journal-title":"Pharmacol. Res."},{"key":"854_CR25","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/jcmm.12674","volume":"20","author":"C Meana","year":"2016","unstructured":"Meana, C. et al. Correlation between endogenous polyamines in human cardiac tissues and clinical parameters in patients with heart failure. J. Cell. Mol. Med. 20, 302\u2013312 (2016).","journal-title":"J. Cell. Mol. Med."},{"key":"854_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cardfail.2013.01.001","volume":"19","author":"WHW Tang","year":"2013","unstructured":"Tang, W. H. W. et al. Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure. J. Card. Fail. 19, 87\u201393 (2013).","journal-title":"J. Card. Fail."},{"key":"854_CR27","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1053\/j.gastro.2025.04.025","volume":"169","author":"LA Bolte","year":"2025","unstructured":"Bolte, L. A., Bj\u00f6rk, J. R., Gacesa, R. & Weersma, R. K. Pharmacomicrobiomics: the role of the gut microbiome in immunomodulation and cancer therapy. Gastroenterology 169, 813\u2013827 (2025).","journal-title":"Gastroenterology"},{"key":"854_CR28","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105, 16731\u201316736 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"854_CR29","doi-asserted-by":"publisher","first-page":"1826748","DOI":"10.1080\/19490976.2020.1826748","volume":"12","author":"M Lenoir","year":"2020","unstructured":"Lenoir, M. et al. Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3. Gut Microbes 12, 1826748 (2020).","journal-title":"Gut Microbes"},{"key":"854_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2505119","volume":"17","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Faecalibacterium prausnitzii prevents age-related heart failure by suppressing ferroptosis in cardiomyocytes through butyrate-mediated LCN2 regulation. Gut Microbes 17, 2505119 (2025).","journal-title":"Gut Microbes"},{"key":"854_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52097-9","volume":"15","author":"A Ravikrishnan","year":"2024","unstructured":"Ravikrishnan, A. et al. Gut metagenomes of Asian octogenarians reveal metabolic potential expansion and distinct microbial species associated with aging phenotypes. Nat. Commun. 15, 7751 (2024).","journal-title":"Nat. Commun."},{"key":"854_CR32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM199702203360801","volume":"336","author":"Digitalis Investigation Group.","year":"1997","unstructured":"Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N. Engl. J. Med. 336, 525\u2013533 (1997).","journal-title":"N. Engl. J. Med."},{"key":"854_CR33","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1056\/NEJMoa2415471","volume":"393","author":"U Bavendiek","year":"2025","unstructured":"Bavendiek, U. et al. Digitoxin in patients with heart failure and reduced ejection fraction. N. Engl. J. Med. 393, 1155\u20131165 (2025).","journal-title":"N. Engl. J. Med."},{"key":"854_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","volume":"14","author":"J Hartupee","year":"2017","unstructured":"Hartupee, J. & Mann, D. L. Neurohormonal activation in heart failure with reduced ejection fraction. Nat. Rev. Cardiol. 14, 30\u201338 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"854_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11897-016-0289-5","volume":"13","author":"WG Hunter","year":"2016","unstructured":"Hunter, W. G., Kelly, J. P., McGarrah, R. W., Kraus, W. E. & Shah, S. H. Metabolic dysfunction in heart failure: diagnostic, prognostic, and pathophysiologic insights from metabolomic profiling. Curr. Heart Fail. Rep. 13, 119\u2013131 (2016).","journal-title":"Curr. Heart Fail. Rep."},{"key":"854_CR36","doi-asserted-by":"publisher","first-page":"e0227365","DOI":"10.1371\/journal.pone.0227365","volume":"15","author":"A Lund","year":"2020","unstructured":"Lund, A. et al. Plasma kynurenines and prognosis in patients with heart failure. PLoS ONE 15, e0227365 (2020).","journal-title":"PLoS ONE"},{"key":"854_CR37","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cardfail.2017.06.007","volume":"23","author":"CCK Mayerhofer","year":"2017","unstructured":"Mayerhofer, C. C. K. et al. Increased secondary\/primary bile acid ratio in chronic heart failure. J. Card. Fail. 23, 666\u2013671 (2017).","journal-title":"J. Card. Fail."},{"key":"854_CR38","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/s41564-021-00970-4","volume":"6","author":"MF Laursen","year":"2021","unstructured":"Laursen, M. F. et al. Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut. Nat. Microbiol. 6, 1367\u20131382 (2021).","journal-title":"Nat. Microbiol."},{"key":"854_CR39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1253\/circj.CJ-18-0468","volume":"83","author":"T Hayashi","year":"2019","unstructured":"Hayashi, T. et al. Gut microbiome and plasma microbiome-related metabolites in patients with decompensated and compensated heart failure. Circ. J. 83, 182\u2013192 (2019).","journal-title":"Circ. J."},{"key":"854_CR40","doi-asserted-by":"publisher","first-page":"1076806","DOI":"10.3389\/fcvm.2022.1076806","volume":"9","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure. Front. Cardiovasc. Med. 9, 1076806 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"854_CR41","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1111\/jcmm.16602","volume":"25","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. The cellular function and molecular mechanism of formaldehyde in cardiovascular disease and heart development. J. Cell. Mol. Med. 25, 5358\u20135371 (2021).","journal-title":"J. Cell. Mol. Med."},{"key":"854_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.858192","volume":"13","author":"H Lee","year":"2022","unstructured":"Lee, H. et al. A novel bacterium, Butyricimonas virosa, preventing HFD-induced diabetes and metabolic disorders in mice via GLP-1 receptor. Front. Microbiol. 13, 858192 (2022).","journal-title":"Front. Microbiol."},{"key":"854_CR43","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.eng.2020.05.025","volume":"7","author":"J-L Hu","year":"2021","unstructured":"Hu, J.-L. et al. Gut microbiota community shift with severity of coronary artery disease. Engineering 7, 1715\u20131724 (2021).","journal-title":"Engineering"},{"key":"854_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-02209-w","volume":"21","author":"J Liu","year":"2021","unstructured":"Liu, J., Hu, J., Tan, L., Zhou, Q. & Wu, X. Abnormalities in lysine degradation are involved in early cardiomyocyte hypertrophy development in pressure-overloaded rats. BMC Cardiovasc. Disord. 21, 403 (2021).","journal-title":"BMC Cardiovasc. Disord."},{"key":"854_CR45","doi-asserted-by":"publisher","first-page":"13892","DOI":"10.3390\/ijms241813892","volume":"24","author":"J Modrego","year":"2023","unstructured":"Modrego, J. et al. Gut microbiota and derived short-chain fatty acids are linked to evolution of heart failure patients. Int. J. Mol. Sci. 24, 13892 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"854_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.123.010813","volume":"17","author":"T Kretzschmar","year":"2024","unstructured":"Kretzschmar, T. et al. Metabolic profiling identifies 1-MetHis and 3-IPA as potential diagnostic biomarkers for patients with acute and chronic heart failure with reduced ejection fraction. Circ. Heart. Fail. 17, e010813 (2024).","journal-title":"Circ. Heart. Fail."},{"key":"854_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/all.16684","author":"H Shao","year":"2025","unstructured":"Shao, H. et al. Bifidobacterium breve M-16V alleviates cow\u2019s milk allergy in a mouse model via gut microbiota-derived indole-3-propionic acid-aryl hydrocarbon receptor signaling axis. Allergy https:\/\/doi.org\/10.1111\/all.16684 (2025).","journal-title":"Allergy"},{"key":"854_CR48","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.clnu.2023.04.001","volume":"42","author":"C-S Kim","year":"2023","unstructured":"Kim, C.-S., Jung, S., Hwang, G.-S. & Shin, D.-M. Gut microbiota indole-3-propionic acid mediates neuroprotective effect of probiotic consumption in healthy elderly: a randomized, double-blind, placebo-controlled, multicenter trial and in vitro study. Clin. Nutr. 42, 1025\u20131033 (2023).","journal-title":"Clin. Nutr."},{"key":"854_CR49","doi-asserted-by":"publisher","unstructured":"Mamic, P., Shi, H., Huang, K. C. & Snyder, M. P. Systolic heart failure, gut microbiome, multi-omics dataset. figshare https:\/\/doi.org\/10.6084\/m9.figshare.30422413.v1 (2025).","DOI":"10.6084\/m9.figshare.30422413.v1"},{"key":"854_CR50","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.chom.2014.08.014","volume":"16","author":"The Integrative HMP Research Network Consortium.","year":"2014","unstructured":"The Integrative HMP Research Network Consortium. The Integrative Human Microbiome Project: dynamic analysis of microbiome\u2013host omics profiles during periods of human health and disease. Cell Host Microbe 16, 276\u2013289 (2014).","journal-title":"Cell Host Microbe"},{"key":"854_CR51","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41591-019-0414-6","volume":"25","author":"SM Sch\u00fcssler-Fiorenza Rose","year":"2019","unstructured":"Sch\u00fcssler-Fiorenza Rose, S. M. et al. A longitudinal big data approach for precision health. Nat. Med. 25, 792\u2013804 (2019).","journal-title":"Nat. Med."},{"key":"854_CR52","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","volume":"35","author":"CP Green","year":"2000","unstructured":"Green, C. P., Porter, C. B., Bresnahan, D. R. & Spertus, J. A. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J. Am. Coll. Cardiol. 35, 1245\u20131255 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"854_CR53","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1017\/S1368980016002421","volume":"20","author":"JL Hollis","year":"2017","unstructured":"Hollis, J. L. et al. Assessing the relative validity of the Scottish Collaborative Group FFQ for measuring dietary intake in adults. Public Health Nutr. 20, 449\u2013455 (2017).","journal-title":"Public Health Nutr."},{"key":"854_CR54","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"854_CR55","doi-asserted-by":"publisher","DOI":"10.7717\/peerj-cs.104","volume":"3","author":"J Lu","year":"2017","unstructured":"Lu, J., Breitwieser, F. P., Thielen, P. & Salzberg, S. L. Bracken: estimating species abundance in metagenomics data. PeerJ Comput. Sci. 3, e104 (2017).","journal-title":"PeerJ Comput. Sci."},{"key":"854_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-3-r46","volume":"15","author":"DE Wood","year":"2014","unstructured":"Wood, D. E. & Salzberg, S. L. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol. 15, R46 (2014).","journal-title":"Genome Biol."},{"key":"854_CR57","doi-asserted-by":"publisher","first-page":"e65088","DOI":"10.7554\/eLife.65088","volume":"10","author":"F Beghini","year":"2021","unstructured":"Beghini, F. et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife 10, e65088 (2021).","journal-title":"eLife"},{"key":"854_CR58","doi-asserted-by":"publisher","first-page":"D459","DOI":"10.1093\/nar\/gkt1103","volume":"42","author":"R Caspi","year":"2014","unstructured":"Caspi, R. et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway\/genome eatabases. Nucleic Acids Res. 42, D459\u2013D471 (2014).","journal-title":"Nucleic Acids Res."},{"key":"854_CR59","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"854_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10927-1","volume":"10","author":"H Mallick","year":"2019","unstructured":"Mallick, H. et al. Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences. Nat. Commun. 10, 3136 (2019).","journal-title":"Nat. Commun."},{"key":"854_CR61","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00570-22","volume":"91","author":"DA Pensinger","year":"2023","unstructured":"Pensinger, D. A. et al. Butyrate differentiates permissiveness to Clostridioides difficile infection and influences growth of diverse C. difficile isolates. Infect. Immun. 91, e0057022 (2023).","journal-title":"Infect. Immun."},{"key":"854_CR62","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mas.21540","volume":"39","author":"LK Pino","year":"2020","unstructured":"Pino, L. K. et al. The Skyline ecosystem: informatics for quantitative mass spectrometry proteomics. Mass Spectrom. Rev. 39, 229\u2013244 (2020).","journal-title":"Mass Spectrom. Rev."},{"key":"854_CR63","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.4049\/jimmunol.2300729","volume":"212","author":"K Abe","year":"2024","unstructured":"Abe, K. et al. Cross-platform comparison of highly sensitive immunoassays for inflammatory markers in a COVID-19 cohort. J. Immunol. 212, 1244\u20131253 (2024).","journal-title":"J. Immunol."},{"key":"854_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35807-4","volume":"8","author":"K Contrepois","year":"2018","unstructured":"Contrepois, K. et al. Cross-platform comparison of untargeted and targeted lipidomics approaches on aging mouse plasma. Sci. Rep. 8, 17747 (2018).","journal-title":"Sci. Rep."},{"key":"854_CR65","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1074\/mcp.M114.046508","volume":"14","author":"K Contrepois","year":"2015","unstructured":"Contrepois, K., Jiang, L. & Snyder, M. Optimized analytical procedures for the untargeted metabolomic profiling of human urine and plasma by combining hydrophilic interaction (HILIC) and reverse-phase liquid chromatography (RPLC)\u2013mass spectrometry. Mol. Cell. Proteomics 14, 1684\u20131695 (2015).","journal-title":"Mol. Cell. Proteomics"},{"key":"854_CR66","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1021\/acs.analchem.8b05592","volume":"91","author":"S Fan","year":"2019","unstructured":"Fan, S. et al. Systematic error removal using random forest for normalizing large-scale untargeted lipidomics data. Anal. Chem. 91, 3590\u20133596 (2019).","journal-title":"Anal. Chem."},{"key":"854_CR67","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"854_CR68","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-021-03707-9","volume":"595","author":"S Han","year":"2021","unstructured":"Han, S. et al. A metabolomics pipeline for mechanistic interrogation of the gut microbiome. Nature 595, 415\u2013420 (2021).","journal-title":"Nature"},{"key":"854_CR69","doi-asserted-by":"publisher","unstructured":"Shi, H., & Mamic, P. Gut microbiome shifts in chronic systolic heart failure are associated with disease severity and clinical improvement. Zenodo https:\/\/doi.org\/10.5281\/zenodo.20756551 (2026).","DOI":"10.5281\/zenodo.20756551"}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-026-00854-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-026-00854-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-026-00854-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:38:47Z","timestamp":1791826727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-026-00854-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":69,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["854"],"URL":"https:\/\/doi.org\/10.1038\/s44161-026-00854-y","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.P.S. declares competing interests related to his role as a cofounder and scientific advisor of Personalis, SensOmics, Qbio, January AI, Fodsel, Filtricine, Protos, RTHM, Iollo, Marble Therapeutics, Crosshair Therapeutics, NextThought and Mirvie. He is a scientific advisor of Jupiter, Neuvivo, Swaza, Mitrix, Yuvan, TranscribeGlass and Applied Cognition. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}